07:00 , Apr 16, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Chronic obstructive pulmonary disorder (COPD) Muscarinic acetylcholine receptor M3 (CHRM3)(HM3) In vitro and in vivo studies identified 4-hydroxyl(diphenyl)methyl-substituted quinuclidines as...